Medicare Experts Mull Idea Of U.S. Comparative Effectiveness Review Agency
This article was originally published in The Gray Sheet
Executive Summary
Impressed by the success of the UK's comparative effectiveness health care agency NICE, Medicare payment expert Gail Wilensky is leading a push for a similar body in the United States - and at least one major stakeholder, Johnson & Johnson, appears willing to contemplate the idea
You may also be interested in...
Comparative-Effectiveness Policies Gaining Momentum In Washington
Funding comparative-effectiveness research to slow growth in health care spending is building momentum this year among health policy and payor circles
Comparative-Effectiveness Policies Gaining Momentum In Washington
Funding comparative-effectiveness research to slow growth in health care spending is building momentum this year among health policy and payor circles
Renal Stenting Coverage Reconsidered: AHRQ Comparative Analysis Effect
CMS' decision last week to reconsider its national coverage policy for renal artery angioplasty and stenting is the agency's first coverage action to grow out of the Effective Health Care Program, the Agency for Healthcare Research & Quality's new comparative effectiveness review arm